The endoscopy procedure uses an endoscope to observe the interior of a hollow organ or cavity of the body. Radiofrequency ablation (RFA) is an endoscopic therapy used primarily to treat Barrett's esophagus. RFA uses an array of parallel alternating electrodes to deliver radiofrequency energy that heats the lining of the gastrointestinal tract, destroying the tissue. Unlike several other medical imaging techniques, endoscopes are inserted directly into the organ.
MARKET DYNAMICS
The endoscope-radiofrequency ablation (RFA) market is expected to grow due to a rise in the geriatric population that is highly responsive to pain and chronic disorders. However, the shortage of skilled professionals that lack complete know-how of endoscopic RFA treatment is restraining the market growth. Moreover, a rise in the need for the development of advanced minimally invasive surgical procedures has expected to benefit the growth of the market in the forecast period.
MARKET SCOPE
The "Endoscope-Radiofrequency Ablation (RFA) Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of in endoscope-radiofrequency ablation (RFA) market with detailed market segmentation by type, reptile, mode of action and geography. The endoscope-radiofrequency ablation (RFA) market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in endoscope-radiofrequency ablation (RFA) market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The endoscope-radiofrequency ablation (RFA) market is segmented on the basis of application. Based on application the market is segmented as cardiology applications, pain management, oncology applications and other applications.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in endoscope-radiofrequency ablation (RFA) market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The endoscope-radiofrequency ablation (RFA) market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting endoscope-radiofrequency ablation (RFA) market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the endoscope-radiofrequency ablation (RFA) market in these regions.
MARKET PLAYERS
The report covers key developments in the in endoscope-radiofrequency ablation (RFA) market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in endoscope-radiofrequency ablation (RFA) market are anticipated to have lucrative growth opportunities in the future with the rising demand for in endoscope-radiofrequency ablation (RFA) market in the global market. Below mentioned is the list of few companies engaged in the endoscope-radiofrequency ablation (RFA) market.
The report also includes the profiles of key in endoscope-radiofrequency ablation (RFA) market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- AngioDynamics, Inc.
- Arthrex, Inc.
- AtriCure, Inc.
- Boston Scientific Corporation
- Conmed Corporation
- Halyard Health, Inc.
- Hologic, Inc.
- Medtronic Plc.
- Smith & Nephew Plc.
- Stryker Corporation
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.